免疫生物研究所の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/12/20 | 1,250 | 1,259 | 1,224 | 1,226 | -26 | -2.1% | 86,400 |
| 2013/12/19 | 1,260 | 1,314 | 1,252 | 1,252 | +2 | +0.2% | 75,100 |
| 2013/12/18 | 1,256 | 1,267 | 1,250 | 1,250 | -20 | -1.6% | 30,500 |
| 2013/12/17 | 1,260 | 1,281 | 1,250 | 1,270 | +10 | +0.8% | 40,500 |
| 2013/12/16 | 1,321 | 1,326 | 1,260 | 1,260 | -69 | -5.2% | 61,300 |
| 2013/12/13 | 1,335 | 1,350 | 1,329 | 1,329 | -15 | -1.1% | 37,200 |
| 2013/12/12 | 1,350 | 1,375 | 1,332 | 1,344 | -18 | -1.3% | 43,000 |
| 2013/12/11 | 1,367 | 1,373 | 1,355 | 1,362 | -14 | -1% | 29,600 |
| 2013/12/10 | 1,360 | 1,385 | 1,355 | 1,376 | +18 | +1.3% | 32,400 |
| 2013/12/09 | 1,385 | 1,390 | 1,356 | 1,358 | +3 | +0.2% | 32,900 |
| 2013/12/06 | 1,429 | 1,444 | 1,350 | 1,355 | -51 | -3.6% | 96,400 |
| 2013/12/05 | 1,337 | 1,425 | 1,335 | 1,406 | +65 | +4.8% | 138,200 |
| 2013/12/04 | 1,368 | 1,369 | 1,329 | 1,341 | -16 | -1.2% | 59,900 |
| 2013/12/03 | 1,366 | 1,370 | 1,340 | 1,357 | +7 | +0.5% | 48,700 |
| 2013/12/02 | 1,340 | 1,373 | 1,335 | 1,350 | +11 | +0.8% | 47,600 |
| 2013/11/29 | 1,330 | 1,344 | 1,330 | 1,339 | +6 | +0.5% | 19,700 |
| 2013/11/28 | 1,350 | 1,350 | 1,330 | 1,333 | -21 | -1.6% | 35,200 |
| 2013/11/27 | 1,375 | 1,375 | 1,351 | 1,354 | -23 | -1.7% | 23,000 |
| 2013/11/26 | 1,372 | 1,390 | 1,367 | 1,377 | ±0 | ±0% | 20,200 |
| 2013/11/25 | 1,387 | 1,399 | 1,371 | 1,377 | -10 | -0.7% | 26,800 |
| 2013/11/22 | 1,401 | 1,407 | 1,387 | 1,387 | -9 | -0.6% | 36,300 |
| 2013/11/21 | 1,406 | 1,420 | 1,393 | 1,396 | -19 | -1.3% | 32,700 |
| 2013/11/20 | 1,386 | 1,420 | 1,385 | 1,415 | +13 | +0.9% | 46,000 |
| 2013/11/19 | 1,406 | 1,430 | 1,402 | 1,402 | +1 | +0.1% | 37,800 |
| 2013/11/18 | 1,410 | 1,427 | 1,390 | 1,401 | +21 | +1.5% | 48,500 |
| 2013/11/15 | 1,349 | 1,395 | 1,349 | 1,380 | +31 | +2.3% | 28,700 |
| 2013/11/14 | 1,330 | 1,365 | 1,330 | 1,349 | +15 | +1.1% | 31,200 |
| 2013/11/13 | 1,351 | 1,364 | 1,332 | 1,334 | -31 | -2.3% | 26,200 |
| 2013/11/12 | 1,308 | 1,389 | 1,300 | 1,365 | +27 | +2% | 62,500 |
| 2013/11/11 | 1,400 | 1,401 | 1,338 | 1,338 | -62 | -4.4% | 39,400 |
| 2013/11/08 | 1,360 | 1,407 | 1,360 | 1,400 | +10 | +0.7% | 29,600 |
| 2013/11/07 | 1,409 | 1,420 | 1,390 | 1,390 | -25 | -1.8% | 31,500 |
| 2013/11/06 | 1,460 | 1,471 | 1,396 | 1,415 | -60 | -4.1% | 44,000 |
| 2013/11/05 | 1,361 | 1,490 | 1,351 | 1,475 | +114 | +8.4% | 54,000 |
| 2013/11/01 | 1,441 | 1,449 | 1,310 | 1,361 | -89 | -6.1% | 89,200 |
| 2013/10/31 | 1,505 | 1,513 | 1,450 | 1,450 | -50 | -3.3% | 56,500 |
| 2013/10/30 | 1,506 | 1,517 | 1,500 | 1,500 | -13 | -0.9% | 49,200 |
| 2013/10/29 | 1,504 | 1,549 | 1,502 | 1,513 | +10 | +0.7% | 43,700 |
| 2013/10/28 | 1,525 | 1,525 | 1,500 | 1,503 | -3 | -0.2% | 24,800 |
| 2013/10/25 | 1,534 | 1,534 | 1,500 | 1,506 | -2 | -0.1% | 50,900 |
| 2013/10/24 | 1,498 | 1,510 | 1,490 | 1,508 | -7 | -0.5% | 75,900 |
| 2013/10/23 | 1,535 | 1,547 | 1,515 | 1,515 | -20 | -1.3% | 59,600 |
| 2013/10/22 | 1,526 | 1,550 | 1,511 | 1,535 | -66 | -4.1% | 120,000 |
| 2013/10/21 | 1,583 | 1,618 | 1,580 | 1,601 | +25 | +1.6% | 80,700 |
| 2013/10/18 | 1,590 | 1,590 | 1,561 | 1,576 | +17 | +1.1% | 57,100 |
| 2013/10/17 | 1,597 | 1,597 | 1,545 | 1,559 | +2 | +0.1% | 88,700 |
| 2013/10/16 | 1,585 | 1,608 | 1,557 | 1,557 | -54 | -3.4% | 101,300 |
| 2013/10/15 | 1,657 | 1,677 | 1,592 | 1,611 | -26 | -1.6% | 130,100 |
| 2013/10/11 | 1,674 | 1,700 | 1,635 | 1,637 | -1 | -0.1% | 223,100 |
| 2013/10/10 | 1,626 | 1,680 | 1,601 | 1,638 | -10 | -0.6% | 110,700 |
2851～
2900
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「免疫生物」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 免疫生物 | 47,700円 | +5.8% | +14.8% | 1.26% | 16.77倍 | 2.93倍 |
|
体外診断薬や研究用抗体製販・受託。遺伝子組み換えカイコは細胞培養足場材や化粧品展開 |
| ＶＩＳ | 71,000円 | +306.2% | - | 0.00% | 27.41倍 | 2.27倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
| リボミック | 10,200円 | -100.0% | - | 0.00% | - | 1.49倍 |
|
東大発の創薬ベンチャー。ＲＮＡ（リボ核酸）を利用した分子標的薬（アプタマー医薬）を開発 |
| カルナバイオ | 22,200円 | +13.5% | - | 0.00% | - | 3.05倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
| クリングル | 48,700円 | -11.3% | - | 0.00% | - | 2.10倍 |
|
阪大発創薬ベンチャー。細胞増殖等機能持つＨＧＦタンパク利用した難治性疾患治療薬を開発 |
市場注目の銘柄
チャート関連のコラム
